Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam tria...
Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial
About this item
Full title
Author / Creator
Verstraete, M , Debucquoy, A , Dekervel, J , van Pelt, J , Verslype, C , Devos, E , Chiritescu, G , Dumon, K , D'Hoore, A , Gevaert, O , Sagaert, X , Van Cutsem, E and Haustermans, K
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Background:
This study characterises molecular effect of bevacizumab, and explores the relation of molecular and genetic markers with response to bevacizumab combined with chemoradiotherapy (CRT).
Methods:
From a subset of 59 patients of 84 rectal cancer patients included in a phase II study combining bevacizumab with CRT, tumour and blood...
Alternative Titles
Full title
Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4402460
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4402460
Other Identifiers
ISSN
0007-0920
E-ISSN
1532-1827
DOI
10.1038/bjc.2015.93
